Cargando…
Engineering T Cell Development for the Next Generation of Stem Cell-Derived Immunotherapies
Engineered T cells are at the leading edge of clinical cell therapy. T cell therapies have had a remarkable impact on patient care for a subset of hematological malignancies. This foundation has motivated the development of off-the-shelf engineered cell therapies for a broad range of devastating ind...
Autores principales: | Michaels, Yale S., Durland, Lauren J., Zandstra, Peter W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624212/ https://www.ncbi.nlm.nih.gov/pubmed/37928777 http://dx.doi.org/10.1089/genbio.2023.0008 |
Ejemplares similares
-
Multi-objective optimization reveals time- and dose-dependent inflammatory cytokine-mediated regulation of human stem cell derived T-cell development
por: Edgar, John M., et al.
Publicado: (2022) -
Engineered human pluripotent stem cell-derived natural killer cells: the next frontier for cancer immunotherapy
por: Zhu, Huang, et al.
Publicado: (2019) -
DLL4 and VCAM1 enhance the emergence of T cell–competent hematopoietic progenitors from human pluripotent stem cells
por: Michaels, Yale S., et al.
Publicado: (2022) -
Nanobody Engineering: Toward Next Generation Immunotherapies and Immunoimaging of Cancer
por: Chanier, Timothée, et al.
Publicado: (2019) -
Harnessing natural killer cells to develop next‐generation cellular immunotherapy
por: Liu, Siyao, et al.
Publicado: (2022)